Evaluation of androgen receptor status in urothelial carcinoma of the urinary bladder in Egyptian patients: an immunohistochemical study

African Journal of Urology - 2020
Mohamed Wagih1, Marwa Kamel2
1Department of Pathology, Faculty of Medicine, Beni-Suef University, Beni-Suef, Egypt
2Unit of Pharmacology, Department of Tumor Biology, National Cancer Institute, Cairo University, Cairo, Egypt

Tóm tắt

Abstract Background The roles of androgen and androgen receptor (AR) signaling in the oncogenesis of prostate cancer are very well established. What is more poorly understood is the role of AR in other human malignancies including bladder cancer. The incidence of bladder cancer is much higher in males than females, but the exact etiology has not been fully elucidated. This gender disparity has raised the possibility of the AR pathway being involved in the genesis of this disease. Thereby, the aim of this work was to evaluate the expression of AR in a group of Egyptian patients with urothelial bladder carcinoma and to assess whether its expression was correlated with other pathological tumor features. Urothelial bladder carcinoma tissue samples from 50 patients were studied by immunostaining for AR expression in tumor cells. Results AR was positively expressed in 29 (58%) patients, while negative expression was observed in 21 (42%) patients. No statistically significant difference in AR expression with respect to tumor grade (P = 0.07) and pT stage (P = 0.09) was observed. Conclusions The results obtained in this study indicates a clinical value of the AR expression in Egyptian patients with urothelial bladder carcinoma, providing the basis for further studies to evaluate its role and the possibility of new target-based therapies for urothelial bladder carcinoma.

Từ khóa


Tài liệu tham khảo

Siegel R, Miller K, Jemal A (2016) Cancer statistics, 2016. CA Cancer J Clin 66:7–30

Ibrahim AS, Khaled HM, Mikhail NN, Baraka H, Kamel H (2014) Cancer incidence in Egypt: results of the national population-based cancer registry program. J Cancer Epidemiol 2014:437971

Burger M, Catto J, Dalbagni G, Grossman H, Herr H, Karakiewicz P, Kassouf W, Kiemeney L, Vecchia C, Shariat S, Lotan Y (2013) Epidemiology and risk factors of urothelial bladder cancer. Eur Urol 63:234–241

Ide H, Inoue S, Miyamoto H (2017) Histopathological and prognostic significance of the expression of sex hormone receptors in bladder cancer: a meta-analysis of immunohistochemical studies. PLoS ONE 12(3):e0174746

Sievert KD, Amend B, Nagele U et al (2009) Economic aspects of bladder cancer: what are the benefits and costs? World J Urol 27:295–300

Siegel RL, Miller KD, Jemal A (2017) Cancer statistics 2017. CA Cancer J Clin 67(1):7–30

Siegel R, Naishadham D, Jemal A (2012) Cancer statistics. CA Cancer J Clin 62:10–29

Dobruch J, Daneshmand S, Fisch M, Lotan Y, Noon AP, Resnick MJ, Shariat SF, Zlotta AR, Boorjian SA (2016) Gender and bladder cancer: a collaborative review of etiology, biology, and outcomes. Eur Urol 69(2):300–310

Nam J, Park S, Lee S, Chung M (2014) Prognostic value of sex hormone receptor expression in non muscle invasive bladder cancer. Yonsei Med J 55:1214–1221

Eble JN, Sauter G, Epstein J et al (2004) World Health Organization classification of tumours. In: Pathology and genetics of tumours of the urinary system and male genital organs, chapter 2. Lyon: IARC Press

Greene FL, Page DL, Fleming ID et al (2002) AJCC Cancer staging manual, 6th edn. Springer, New York

Tuygun C, Kankaya D, Imamoglu A, Sertcelik A, Zengin K, Oktay M et al (2011) Sex specific hormone receptors in urothelial carcinomas of the human urinary bladder: a comparative analysis of clinicopathological features and survival outcomes according to receptor expression. Urol Oncol 29:43–51

Mahdavifar N, Ghoncheh M, Pakzad R, Momenimovahed Z, Salehiniya H (2016) Epidemiology, incidence and mortality of bladder cancer and their relationship with the development index in the World. Asian Pac J Cancer Prev 17(1):381–386

Yavari P, Sadrolhefazi B, Mohagheghi M, Mehrazin R (2009) A descriptive retrospective study of bladder cancer at a hospital in Iran (1973–2003). Asian Pac J Cancer Prev 10:681–684

Ide H, Miyamoto H (2015) Steroid hormone receptor signals as prognosticators for urothelial tumor. Dis Markers 2015:840640

Li P, Chen J, Miyamoto H (2017) Androgen receptor signaling in bladder cancer. Cancers (Basel) 9(2):20

Inoue S, Mizushima T, Miyamoto H (2018) Role of the androgen receptor in urothelial cancer. Mol Cell Endocrinol 465:73–81

Miyazaki J, Nishiyama H (2017) Epidemiology of urothelial carcinoma. Int J Urol 24(10):730–734

Boorjian S, Ugras S, Mongan N, Gudas L, You X, Tickoo S, Scherr D (2004) Androgen receptor expression is inversely correlated with pathologic tumour stage in bladder cancer. Urology 64:383–388

Miyamoto H, Yao J, Chaux A, Zheng Y, Hsu I, Izumi K, Chang C, Messing E, Netto G, Yeh S (2011) Expression of androgen and oestrogen receptors and its prognostic significance in urothelial neoplasm of the urinary bladder. BJU Int 109:1716–1726

Mashhadi R, Pourmand G, Kosari F, Mehrsai A, Salem S, PourmandM Alatab S, Khonsari M, Heydari F, Beladi L, Alizadeh F (2014) Role of steroid hormone receptors in formation and progression of bladder carcinoma: a case control study. Urol Oncol 11(6):1–6

Mir C, Shariat S, Van der Kwast T et al (2011) Loss of androgen receptor expression is not associated with pathological stage, grade, gender or outcome in bladder cancer: a large multi-institutional study. BJU Int 108:24–30

Miyamoto H, Yang Z, Chen Y et al (2007) Promotion of bladder cancer development and progression by androgen receptor signals. J Natl Cancer Inst 99(7):558–568

Hata S, Ise K, Azmahani A, Konosu-Fukaya S, McNamara KM, Fujishima F, Shimada K, Mitsuzuka K, Arai Y, Sasano H, Nakamura Y (2017) Expression of AR, 5αR1 and 5αR2 in bladder urothelial carcinoma and relationship to clinicopathological factors. Life Sci 190:15–20

Chen F, Langenstroer P, Zhang G et al (2003) Androgen dependent regulation of bacillus Calmette-Guerin induced interleukin-6 expression in human transitional carcinoma cell lines. J Urol 170:2009–2013

Izumi K, Zheng Y, Hsu J, Chang C, Miyamoto H (2013) Androgen receptor signals regulate UDP-glucuronosyltransferases in the urinary bladder: a potential mechanism of androgen induced bladder carcinogenesis. Mol Carcinog 52:94–102

Johnson DT, Hooker E, Luong R, Yu EJ, He Y, Gonzalgo ML, Sun Z (2016) Conditional expression of the androgen receptor increases susceptibility of bladder cancer in mice. PLoS ONE 11(2):e0148851

Thông tin
Thông tin xuất bản

African Journal of Urology

Thông tin tác giả